NR1H4 and obesity due to melanocortin 4 receptor deficiency: Nevertheless, conflicting results have been reported in relation to the possible role of FXR in obesity-associated metabolic disease and its inhibition and activation at the intestinal level have been shown to improve obesity, insulin resistance, and NAFLD [55].